MiNK Therapeutics Inc.
INKT | NASDAQ
$12.10
-$0.15 (-1.22%)
Sep 22, 2026, 12:20 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 8.81B | 9.53M | 13.36M | 14.28M | 1.68M | 3.23M | 4.58M | 6.33M | 9.31M | 5.82M | 3.37M | 6.4M | 10.62M | 14.89M | 19.64M | 24.16M | 29.85M | 34.69M | 38.89M | 819.45K | 1.66M | n/a |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 318.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | 0 | 0 | 0 | 0 | 0 | n/a | 2.56M | 0 | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 23K | 35K | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 489.79M | 232.26K | 211.2K | 32 | 55.21K | 108.71K | 164.24K | 11.2K | 61.14K | 122.48K | 177.96K | 29.34K | 166.03K | 320.89K | 470.3K | 37.52K | 378.13K | 604.64K | 721.32K | 10.87K | 2.37M | -2.69M |
Total Current Assets | 9.3B | 10.02M | 13.85M | 14.53M | 2.01M | 3.58M | 4.99M | 6.58M | 9.47M | 6M | 3.6M | 6.47M | 11.05M | 15.52M | 20.4M | 24.46M | 30.33M | 35.48M | 39.63M | 878.55K | 4.2M | n/a |
Property-Plant & Equipment | n/a | 354.52K | 390.87K | 429.34K | 473.22K | 687.5K | 732.93K | 799.52K | 849.96K | 894.99K | 953.98K | 991.46K | 1.06M | 1.07M | 1.07M | 803.13K | 787.54K | 665.21K | 606.6K | 635.89K | 552.48K | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 318.47M | 354.52K | 390.87K | 429.34K | 473.22K | 687.5K | 732.93K | 799.52K | 849.96K | 894.99K | 953.98K | 991.46K | 1.06M | 1.07M | 1.07M | 803.13K | 787.54K | 665.21K | 606.59K | 3.2M | 552.48K | n/a |
Total Assets | 9.62B | 10.38M | 14.24M | 14.96M | 2.48M | 4.27M | 5.72M | 7.37M | 10.32M | 6.89M | 4.55M | 7.46M | 12.11M | 16.59M | 21.47M | 25.26M | 31.12M | 36.14M | 40.24M | 4.08M | 4.75M | n/a |
Account Payables | 3.92B | 3.39M | 3.43M | 3.69M | 3.31M | 2.66M | 2.73M | 2.36M | 3.2M | 3.49M | 3.91M | 4.28M | 4.89M | 6M | 5.82M | 5.17M | 4.79M | 3.73M | 3M | 1.65M | 2.27M | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | 5.18M | 5.73M | 5.51M | 5.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 65.42M | 52.53M | n/a |
Other Current Liabilities | 7.57B | 3.53M | 2.85M | 2.76M | 2.48M | 2.37M | 2.36M | 4.13M | 6.94M | 2.34M | 5.66M | 2.27M | 2.33M | 2.49M | 5.21M | 10.44M | 9.79M | 12.45M | 12.89M | 13.13M | 10.3M | n/a |
Total Current Liabilities | 7.57B | 7.29M | 13.03M | 13.43M | 13.16M | 12.12M | 6.96M | 7.4M | 10.15M | 11.11M | 11.4M | 10.39M | 11.46M | 11.25M | 12.68M | 18.45M | 17.43M | 18.83M | 16.47M | 80.56M | 67.55M | n/a |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | 4.92M | 4.61M | 4.41M | 4.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 15.78M | 15.44M | 15.04M | 14.51M | 13.94M | 13.42M | 12.92M | 12.35M | 11.87M | 11.21M | 10.65M | 10.14M | 9.81M | 9.19M | 58.28K | n/a | 0 | n/a | 27.54K | 383.06K | 53.87M |
Total Long-Term Liabilities | n/a | 15.78M | 15.44M | 15.04M | 14.51M | 13.94M | 18.35M | 17.53M | 16.75M | 16.08M | 11.21M | 10.65M | 10.14M | 9.81M | 9.19M | 58.28K | n/a | 0 | n/a | 27.54K | 383.06K | 53.87M |
Total Liabilities | n/a | 23.06M | 28.47M | 28.48M | 27.67M | 26.06M | 25.31M | 24.93M | 26.9M | 27.19M | 22.61M | 21.04M | 21.61M | 21.06M | 21.87M | 18.51M | 17.43M | 18.83M | 16.47M | 80.59M | 67.93M | 53.87M |
Total Debt | n/a | n/a | 5.18M | 5.73M | 5.51M | 5.12M | 4.92M | 4.61M | 4.41M | 4.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 65.42M | 52.53M | n/a |
Book Value | 9.62B | -12.69M | -14.23M | -13.51M | -25.19M | -21.79M | -19.59M | -17.55M | -16.58M | -20.3M | -18.06M | -13.58M | -9.5M | -4.48M | -401.3K | 6.76M | 13.69M | 17.31M | 23.78M | -76.51M | -63.18M | -53.87M |
Book Value Per Share | 1.91K | -2.64 | -3.33 | -3.04 | -6.33 | -5.50 | -5.19 | -4.44 | -4.46 | -5.86 | -5.22 | -3.94 | -2.76 | -1.32 | -0.12 | 2 | 4.07 | 5.17 | 7.23 | -23.28 | -22.25 | -18.97 |
Common Stock | 52K | 51 | 48 | 46 | 40 | 40 | 40 | 395 | 394 | 347 | 346 | 345 | 345 | 343 | 339 | 338 | 337 | 336 | 335 | 242 | 87 | n/a |
Retained Earnings | -162.55B | -159.42M | -156.68M | -154.07M | -151.19M | -146.95M | -144.18M | -141.72M | -139.91M | -137.21M | -133.4M | -127.94M | -122.82M | -116.63M | -110.94M | -103.17M | -96.84M | -90.72M | -82.95M | -77.18M | -62.92M | n/a |
Comprehensive Income | -699.89M | -697.43K | -718.92K | -692.11K | -719.32K | -662.44K | -631.58K | -672.84K | -611.38K | -385.78K | -430.95K | -313.19K | -401.81K | -373.8K | -292.47K | -78.28K | 1.3M | -102.5K | -625.27K | -789.34K | -1.34M | -53.87M |
Shareholders Equity | n/a | -12.69M | -14.23M | -13.51M | -25.19M | -21.79M | -19.59M | -17.55M | -16.58M | -20.3M | -18.06M | -13.58M | -9.5M | -4.48M | -401.3K | 6.76M | 13.69M | 17.31M | 23.78M | -76.51M | -63.18M | -53.87M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove INKT